Joel Salazar-Mendiguchía
@joelsmg
A cardiogeneticist with clinical, research, biotech and biopharma experience in cardiomyopathies and heart failure. Opinions are my own
ID: 741028290
https://pubmed.ncbi.nlm.nih.gov/?term=salazar+mendiguchia+OR+salazar+mendiguchia+garcia&sort=date 06-08-2012 17:09:25
1,1K Tweet
700 Takipçi
389 Takip Edilen
In patients with #Takotsubo syndrome, late ventricular function recovery is associated with worse in-hospital outcomes and reduced long-term survival. bit.ly/3XB86SJ #JACC #HeartFailure Jorge Salamanca Viloria Ravi Vazirani Ballesteros
Rethinking the #genetic architecture of #HCM by A/Prof Jodie Ingles at #HCMSummit8 in beautiful Boston! It’s time to move beyond thinking solely about the ‘classic’ 8 #sarcomere #genes #cardiogene #cardiomyopathies
Why should I get a #genetic testing for my #HCM patient? Well, the question should be "why not?" Great talk by Anjali Owens It is useful for family screening, #phenocopies identification, potentially choose appropriate treatment and even as a prognostic tool #HCMSummit8
#CMR in #HCM... from #diagnosis to prognostication. Great overview of several potential uses and techniques by Milind Desai MD MBA at #HCMSummit8 Amazing meeting with a packed room!
The art of stratifying the risk of #SCD in #HCM and the eternal dilemma of #AHA/ACC vs #ESC guidelines approach... Finding the balance between sensibility vs specificity AND the important role of #clinical judgement. Fantastic presentation by Martin Maron, MD at #HCMSummit8
The future is bright for #HCM patients 🫀👩🏼🤝👨🏽 Ahmad Masri walks us through the future medical therapies for nonobstructive HCM at #HCMSummit8 What an incredible time to be part of this journey!
📰 Excited to share our latest paper abour a real gap in knowledge in cardiac amyloidosis: Sudden death The International Society Of Amyloidosis
We analysed mitochondrial variation in cardiomyopathy patients from 100K genomes project and found the HCM causing m.4300A>G in 0.6% of (previously) genotype-"negative" HCM patients humgenomics.biomedcentral.com/articles/10.11… - shall we include it in the testing panels? Robert Pitceathly Will Macken